Search - tctmd.com

Displaying 61 - 73 of 73

Sort: Relevancy | Date

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Video

» Interview

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

March 18, 2019

Video

» Interview

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

March 18, 2019

Video

» Interview

ACC 2019: Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

March 18, 2019

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Video

» Interview

Treatment of AS in Young Patients

June 24, 2024

Video

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

June 26, 2018

Video

» Interview

Preemptive (Early) TAVI in Severe and Moderate AS Patients

June 24, 2024

Video

» On Record

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

August 6, 2025

Video

» Interview

Introducing Target AS

June 24, 2024

Video

Asymptomatic Aortic Stenosis- When to Intervene- - M. Sarano

January 9, 2020

Video

Aortic Insufficiency- Repair Versus Replacement- - E. Girdauskas

January 9, 2020

Video

» Interview

Advances in the Management of AR

June 24, 2024

Advertisement

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

ACC 2019: Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

Treatment of AS in Young Patients

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Preemptive (Early) TAVI in Severe and Moderate AS Patients

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

Introducing Target AS

Asymptomatic Aortic Stenosis- When to Intervene- - M. Sarano

Aortic Insufficiency- Repair Versus Replacement- - E. Girdauskas

Advances in the Management of AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content